Angiogenesis is the formation of new blood vessels from pre-existing ones. Cancer cells can secrete various growth factors like Vascular Endothelial Growth Factor (VEGF) to stimulate angiogenesis, ensuring a continuous supply of oxygen and nutrients. Targeting angiogenesis through drugs like bevacizumab has been a strategy to starve tumors of their blood supply.